Adverse events following ChAdOx1 nCoV-19 (Covisheild) vaccine administered in two-dose regimen: A single centre experience from Sri Lanka
dc.date.accessioned | 2022-07-21T07:33:08Z | |
dc.date.available | 2022-07-21T07:33:08Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 47(1):p.17-25 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/25599 | |
dc.publisher | Ceylon College of Physicians:Rajagiriya | |
dc.subject | Govindapala, D.S. | |
dc.subject | Senarath R.M.U.S. | |
dc.subject | Wijenayake, W. | |
dc.subject | Wijewardena, T.D. | |
dc.subject | Nakkawita, W.M.I.D. | |
dc.subject | Senaratne, U.T.N. | |
dc.subject | Kawyangana, P. | |
dc.subject | De Silva, A.D. | |
dc.subject | Fernando, N.S. | |
dc.subject | ChAdOx1 nCoV-19 vaccine | |
dc.subject | Adverse events | |
dc.subject | Reactogenicity | |
dc.subject | Covisheild | |
dc.subject | Sri Lanka | |
dc.title | Adverse events following ChAdOx1 nCoV-19 (Covisheild) vaccine administered in two-dose regimen: A single centre experience from Sri Lanka | |
dc.type | Article |